Bhutan vs East Asia & Pacific (excluding high income): Immunization, HepB3
Immunization, HepB3 over time
- Bhutan
- East Asia & Pacific (excluding high income)
How they compare
Bhutan currently reports 98.0% against 87.4% in East Asia & Pacific (excluding high income), a difference of 10.6%.
That makes Bhutan's figure about 1.1 times East Asia & Pacific (excluding high income)'s.
The two have swapped places 3 times across 29 shared years of data; in 1996 it was East Asia & Pacific (excluding high income) ahead.
Bhutan ranks 19th and East Asia & Pacific (excluding high income) ranks 16th of 188 countries.
Bhutan has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Bhutan | East Asia & Pacific (excluding high income) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 67.8% | 18.7% | 49.1% | Bhutan |
| 2000s | 92.8% | 74.5% | 18.3% | Bhutan |
| 2010s | 96.8% | 93.7% | 3.1% | Bhutan |
| 2020s | 97.8% | 89.2% | 8.6% | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Bhutan or East Asia & Pacific (excluding high income)?
- Bhutan, at 98.0% against 87.4% in East Asia & Pacific (excluding high income) as of 2024.
- What is the difference in immunization, hepb3 between Bhutan and East Asia & Pacific (excluding high income)?
- 10.6%, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and East Asia & Pacific (excluding high income)?
- 29 years are reported by both, from 1996 to 2024.
- How do Bhutan and East Asia & Pacific (excluding high income) rank globally for immunization, hepb3?
- Bhutan ranks 19th and East Asia & Pacific (excluding high income) ranks 16th of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.